Biobijou Co Ltd
489460
Company Profile
Business description
Biobijou Co Ltd is engaged in the development, manufacturing, and distribution of medical aesthetic products. It offers a comprehensive range of medical aesthetic products designed for professional use such as Hyaluronic Acid (HA) Dermal Fillers, Skin Boosters, Botulinum Toxin, Lipolysis Injections and others.
Contact
947 Hanam-daero
Building A, Room 1516
U1CENTER, Hanam Techno Valley, Pungsan-dong
Gyeonggi-do
Hanam-si
KORT: +82 262359696
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
12
Stocks News & Analysis
stocks
A collection of our best stock opportunities
Our latest articles about where we see opportunities in the market.
stocks
Morningstar analyst reacts to Macquarie Group’s earnings
Banking Analyst Nathan Zaia’s analysis of MQG’s results.
stocks
Undervalued ASX share showing progress in global efforts
More clarity on the path forward in the UK.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,963.50 | 29.20 | 0.33% |
| CAC 40 | 7,800.88 | 33.70 | -0.43% |
| DAX 40 | 23,970.36 | 247.14 | -1.02% |
| Dow JONES (US) | 44,762.98 | 138.94 | -0.31% |
| FTSE 100 | 9,081.44 | 38.87 | -0.43% |
| HKSE | 25,562.13 | 173.78 | 0.68% |
| NASDAQ | 21,139.20 | 30.88 | 0.15% |
| Nikkei 225 | 40,998.27 | 457.96 | -1.10% |
| NZX 50 Index | 12,910.74 | 57.28 | 0.45% |
| S&P 500 | 6,378.28 | 10.36 | -0.16% |
| S&P/ASX 200 | 8,697.70 | 30.80 | 0.36% |
| SSE Composite Index | 3,597.94 | 4.28 | 0.12% |